SignatureFD
ENTA icon

SignatureFD’s Enanta Pharmaceuticals ENTA Stock Holding History

SignatureFD’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.75K Buy
+133
New +$1.77K ﹤0.01% 3218
2024
Q2 		– Sell
-163
Closed -$2.85K – 3158
2024
Q1 		$2.85K Buy
+163
New +$2.16K ﹤0.01% 2702
2023
Q4 		– Sell
-978
Closed -$10.9K – 3170
2023
Q3 		$10.9K Buy
978
+748
+325% +$12K ﹤0.01% 2165
2023
Q2 		$4.92K Buy
230
+192
+505% +$5.66K ﹤0.01% 2522
2023
Q1 		$1.54K Sell
38
-60
-61% -$2.86K ﹤0.01% 2877
2022
Q4 		$4.56K Sell
98
-93
-49% -$4.24K ﹤0.01% 2515
2022
Q3 		$10K Buy
191
+25
+15% +$1.46K ﹤0.01% 2079
2022
Q2 		$8K Sell
166
-226
-58% -$12.3K ﹤0.01% 2221
2022
Q1 		$28K Buy
392
+182
+87% +$11.8K ﹤0.01% 1667
2021
Q4 		$16K Buy
210
+5
+2% +$392 ﹤0.01% 1875
2021
Q3 		$12K Sell
205
-14
-6% -$692 ﹤0.01% 1968
2021
Q2 		$10K Buy
219
+70
+47% +$3.43K ﹤0.01% 1977
2021
Q1 		$7K Buy
149
+41
+38% +$2.04K ﹤0.01% 2005
2020
Q4 		$5K Sell
108
-257
-70% -$11.3K ﹤0.01% 1946
2020
Q3 		$17K Buy
365
+190
+109% +$9.21K ﹤0.01% 1440
2020
Q2 		$9K Buy
175
+83
+90% +$4.3K ﹤0.01% 1599
2020
Q1 		$5K Buy
+92
New +$4.9K ﹤0.01% 1670

Other funds holding ENTA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
True Wealth Design
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

SignatureFD's ENTA Position: Q3 2026 in Review

SignatureFD opened a new position in Enanta Pharmaceuticals (ENTA) in Q3 2026: 133 shares worth $1.75K. The stake represents ﹤0.01% of the portfolio and ranks #3218 among its holdings. This is a return to the name: SignatureFD previously reported a position in ENTA as recently as Q1 2024.

SignatureFD first reported a position in ENTA in Q1 2020 and has held it in 17 quarters since. The position peaked at $28K in Q1 2022. 11 funds tracked by Wall St. Rank hold ENTA as of Q3 2026.

  • SignatureFD held 133 shares of Enanta Pharmaceuticals worth $1.75K as of Q3 2026.
  • Enanta Pharmaceuticals was a new SignatureFD position in Q3 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3218 holding.
  • SignatureFD first reported a position in Enanta Pharmaceuticals in Q1 2020 and has held it in 17 quarters since.
  • SignatureFD's Enanta Pharmaceuticals position peaked at $28K in Q1 2022.
  • 11 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.